Collegium Pharmaceutical, Inc. Common Stock (COLL)

Price$31.78

Value ScoreB

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-39.46%

Price vs S&P 500 (4W)-7.04%

VGM Score62.53

Market Capitalization$1.03B

P/E Ratio (Annual)16.40x

All Metrics

P/CF (Annual)3.13x

Book Value / Share (Quarterly)$9.64

P/TBV (Annual)11.92x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)18.94%

Cash Flow / Share (Quarterly)$10.18

Price vs S&P 500 (YTD)-38.34%

Gross Margin (TTM)60.68%

Net Profit Margin (TTM)9.41%

EPS (TTM)$1.88

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$1.88

Revenue Growth (5Y)20.28%

EPS (Annual)$1.58

ROI (Annual)5.66%

Gross Margin (Annual)59.35%

Net Profit Margin (5Y Avg)9.59%

Cash / Share (Quarterly)$13.01

P/E Basic Excl Extra (TTM)13.76x

Revenue Growth QoQ (YoY)8.87%

EPS Growth (5Y)15.77%

P/E Normalized (Annual)16.40x

ROA (Last FY)3.79%

Revenue Growth TTM (YoY)19.88%

EBITD / Share (TTM)$4.43

ROE (5Y Avg)19.62%

Operating Margin (TTM)21.71%

Cash Flow / Share (Annual)$10.33

P/B Ratio3.30x

P/B Ratio (Quarterly)3.43x

Net Income / Employee (Annual)$148,600

EV / Revenue (TTM)1.97x

Net Interest Coverage (TTM)2.30x

ROA (TTM)4.61%

EPS Growth QoQ (YoY)391.58%

EV / EBITDA (TTM)8.87x

EPS Incl Extra (Annual)$1.58

Current Ratio (Annual)1.57x

Quick Ratio (Quarterly)1.54x

3-Month Avg Trading Volume0.48M

52-Week Price Return15.18%

EV / Free Cash Flow (Annual)4.78x

P/E Incl Extra (TTM)13.76x

Revenue / Employee (TTM)$1,882,600

Tangible BV / Share (Quarterly)$1.72

P/S Ratio (Annual)1.32x

Asset Turnover (Annual)0.47x

52-Week High$50.79

Operating Margin (5Y Avg)16.98%

EPS Excl Extra (Annual)$1.58

CapEx CAGR (5Y)-65.83%

26-Week Price Return-23.53%

Quick Ratio (Annual)1.41x

13-Week Price Return-23.99%

Total Debt / Equity (Annual)2.68x

Current Ratio (Quarterly)1.71x

Enterprise Value$1.57B

Revenue / Share Growth (5Y)17.42%

Asset Turnover (TTM)0.49x

Book Value / Share Growth (5Y)12.10%

Revenue / Employee (Annual)$1,845,300

Inventory Turnover (Annual)8.30x

Pretax Margin (Annual)11.87%

Cash / Share (Annual)$12.20

3-Month Return Std Dev41.94%

Gross Margin (5Y Avg)55.45%

Net Income / Employee (TTM)$177,200

EBITDA CAGR (5Y)24.06%

EBITDA Interim CAGR (5Y)7.74%

ROE (Last FY)20.84%

Net Interest Coverage (Annual)2.68x

EPS Basic Excl Extra (Annual)$1.58

P/FCF (TTM)3.13x

Receivables Turnover (TTM)3.48x

EV / Free Cash Flow (TTM)4.75x

Total Debt / Equity (Quarterly)2.57x

EPS Incl Extra (TTM)$1.88

Receivables Turnover (Annual)3.55x

ROI (TTM)6.87%

P/S Ratio (TTM)1.29x

Pretax Margin (5Y Avg)6.68%

Revenue / Share (Annual)$19.66

Tangible BV / Share (Annual)$1.72

Forward P/E4.40x

Free OCF CAGR (5Y)56.88%

Price vs S&P 500 (52W)-13.02%

P/E Ratio (TTM)13.76x

EPS Growth TTM (YoY)71.17%

Year-to-Date Return-27.41%

5-Day Price Return-1.35%

EPS Normalized (Annual)$1.58

ROA (5Y Avg)4.07%

Net Profit Margin (Annual)8.05%

Month-to-Date Return-0.36%

Cash Flow / Share (TTM)$4.22

EBITD / Share (Annual)$4.23

EPS Growth (3Y)-0.62%

Operating Margin (Annual)20.96%

LT Debt / Equity (Annual)2.59x

P/CF (TTM)3.11x

ROI (5Y Avg)6.13%

P/E Excl Extra (TTM)13.76x

LT Debt / Equity (Quarterly)2.47x

EPS Basic Excl Extra (TTM)$1.88

P/TBV (Quarterly)11.92x

P/B Ratio (Annual)4.85x

Inventory Turnover (TTM)7.83x

Pretax Margin (TTM)13.59%

Book Value / Share (Annual)$9.51

Price vs S&P 500 (13W)-33.74%

Net Margin Growth (5Y)-1.43%

Beta0.75x

P/FCF (Annual)3.15x

Revenue / Share (TTM)$19.88

ROE (TTM)26.74%

52-Week Low$28.73

vGradeB

gGradeB

mGradeD

vgmGradeB

Show chart for

Earnings Surprise History

Q1 261.76est. 1.62

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.08

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
COLLCollegium Pharmaceutical, Inc. Common Stock	B	B	D	$31.78
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Collegium Pharmaceutical is a biopharmaceutical company that develops and commercializes treatments for ADHD and moderate to severe pain in the United States. Its marketed product portfolio includes Jornay PM for ADHD, Belbuca and Xtampza ER for pain management, the Nucynta line (Nucynta ER and IR), and Symproic.